193 related articles for article (PubMed ID: 6403025)
41. A modified SDS agarose gel method for determining factor VIII von Willebrand factor multimers using commercially available reagents.
Miller MA; Palascak JE; Thompson MR; Martelo OJ
Thromb Res; 1985 Sep; 39(6):777-80. PubMed ID: 3936225
[No Abstract] [Full Text] [Related]
42. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes.
Budde U; Schneppenheim R; Plendl H; Dent J; Ruggeri ZM; Zimmerman TS
Thromb Haemost; 1990 Apr; 63(2):312-5. PubMed ID: 2363131
[TBL] [Abstract][Full Text] [Related]
43. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
[TBL] [Abstract][Full Text] [Related]
44. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
[TBL] [Abstract][Full Text] [Related]
45. Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity.
Goudemand J; Mazurier C; Marey A; Caron C; Coupez B; Mizon P; Goudemand M
Br J Haematol; 1992 Feb; 80(2):214-21. PubMed ID: 1550779
[TBL] [Abstract][Full Text] [Related]
46. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
Weiss HJ; Sussman II; Hoyer LW
J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
[TBL] [Abstract][Full Text] [Related]
47. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
48. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
49. A variant of von Willebrand's disease characterized by recessive inheritance and missing triplet structure of von Willebrand factor multimers.
Mannucci PM; Lombardi R; Pareti FI; Solinas S; Mazzucconi MG; Mariani G
Blood; 1983 Nov; 62(5):1000-5. PubMed ID: 6605165
[TBL] [Abstract][Full Text] [Related]
50. Collagen-factor VIII/von Willebrand factor protein interaction.
Kessler CM; Floyd CM; Rick ME; Krizek DM; Lee SL; Gralnick HR
Blood; 1984 Jun; 63(6):1291-8. PubMed ID: 6426548
[TBL] [Abstract][Full Text] [Related]
51. [Diagnosis of von Willebrand's disease subtypes by the analysis of multimeric composition of plasma von Willebrand factor].
Quiroga T; Pérez M; Pereira J; Mezzano D
Rev Med Chil; 1993 Sep; 121(9):987-93. PubMed ID: 8191164
[TBL] [Abstract][Full Text] [Related]
52. Native multimer analysis of plasma and platelet von Willebrand factor compared to denaturing separation: implication for the interpretation of satellite bands.
Hohenstein K; Griesmacher A; Weigel G; Golderer G; Ott HW
Electrophoresis; 2011 Jun; 32(13):1684-91. PubMed ID: 21647922
[TBL] [Abstract][Full Text] [Related]
53. Platelet von Willebrand factor: comparison with plasma von Willebrand factor.
Gralnick HR; Williams SB; McKeown LP; Krizek DM; Shafer BC; Rick ME
Thromb Res; 1985 Jun; 38(6):623-33. PubMed ID: 3927508
[TBL] [Abstract][Full Text] [Related]
54. Multicenter comparison of von Willebrand factor multimer sizing techniques. Report of the Factor VIII and von Willebrand Factor Subcommittee.
Mannucci PM; Abildgaard CF; Gralnick HR; Hill FG; Hoyer LW; Lombardi R; Nilsson IM; Tuddenham E; Meyer D
Thromb Haemost; 1985 Dec; 54(4):873-6. PubMed ID: 3879020
[TBL] [Abstract][Full Text] [Related]
55. Fluid-phase immunoradiometric assay for the detection of qualitative abnormalities of factor VIII/von Willebrand factor in variants of von Willebrand's disease.
Girma JP; Ardaillou N; Meyer D; Lavergne JM; Larrieu MJ
J Lab Clin Med; 1979 Jun; 93(6):926-39. PubMed ID: 312307
[TBL] [Abstract][Full Text] [Related]
56. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
[TBL] [Abstract][Full Text] [Related]
57. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
Miller JL; Kupinski JM; Castella A; Ruggeri ZM
J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
[TBL] [Abstract][Full Text] [Related]
58. Visualization of von Willebrand factor multimers by enzyme-conjugated secondary antibodies.
Brosstad F; Kjønniksen I; Rønning B; Stormorken H
Thromb Haemost; 1986 Apr; 55(2):276-8. PubMed ID: 3520939
[TBL] [Abstract][Full Text] [Related]
59. In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's disease.
Gralnick HR; Williams SB; McKeown LP; Maisonneuve P; Jenneau C; Sultan Y; Rick ME
Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5968-72. PubMed ID: 2994057
[TBL] [Abstract][Full Text] [Related]
60. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
Neugebauer BM; Goy C; Budek I; Seitz R
Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
